Syncona
Limited
2018 Dividend
Scrip Reference Price
29 June 2018
Syncona Limited announces that the scrip reference price for its
2018 dividend will be £2.418. This is the higher of (i) the
prevailing average of the middle market quotations of its ordinary
shares derived from the Daily Official List of the London Stock
Exchange for the ex-dividend date, 21 June
2018, and the four subsequent dealing days and (ii) the net
asset value per ordinary share as at 31 May 2018.[1]
[ENDS]
Enquiries
Syncona Ltd
Siobhan Weaver
Annabel Clay
Tel: +44 (0) 20 7611 2031
Northern Trust International Fund Administration Services
(Guernsey) Limited
Company Secretary
Tel: 01481 745001
Copies of this press release and other corporate information
can be found on the company website at: www.synconaltd.com
About Syncona:
Syncona is a leading FTSE250 healthcare company focused on
investing in and building global leaders in life science. Our
vision is to deliver transformational treatments to patients in
truly innovative areas of healthcare while generating superior
returns for shareholders.
We seek to partner with the best, brightest and most ambitious
minds in science to build globally competitive businesses.
We take a long-term view, underpinned by a deep pool of
capital, and are established leaders in the development of
genetic medicine, particularly gene and cell therapy. We focus on
delivering dramatic efficacy for patients in areas of high unmet
need.
[1] Net asset value per ordinary share (undiluted) as at 31 May
2018